First Name *

Last Name *

Email *

Cell Phone *

I verify that I am an Accredited Investor.

For accredited investorsLive investor Q&A every Monday · 8:00 PM ET · Zoom

ReLiftMD™ Ventures · Reg D 506(c)

ReLift® Centers are opening nationwide.

Invest in the national expansion of the first minimally invasive facial rejuvenation brand, with distributions paid first and equity upside at the exit.*

ReLift patients before and after, with Dr. Summers — Actual patients treated with One Hour ReLift® procedures, developed by Adam Summers, M.D.

Mondays · 8:00 PM ET · Zoom

Get the Annual Report and join the next investor Q&A.

You will receive the Zoom link and reminders by email and text. Accredited investors only; verification is required before any investment.

$50MMRaise · Reg D 506(c) SPV

$100KMinimum investment

25% IRRTarget 3–5 years*

8x+ ROITargeted with IPO*

The expansion is underway

Proven in one clinic. Opening nationwide.

More than 2,200 patients have spent over $32 million on ReLift® procedures. ReLiftMD™ is now opening minimally invasive ReLift® Centers inside partner practices across the country.

With proprietary materials and methods, patients can look ten years younger after a one-hour procedure.

2,200+Patients treated

$32MM+In ReLift® procedures to date

$1MM+Annual revenue per center*

A ReLift patient describing her results — A ReLift® patient, in her own words.

Priority access

Reserve your place before the next round.

01 · Reserve

Your place.

Join the priority reservation list using the form on this page.

02 · No obligation

Simply listen.

Adding your name does not obligate you to invest.

03 · Exclusive access

The investor portal.

View confidential information about the ReLiftMD™ expansion plans.

04 · Limited reserve

First in line.

Reservation-list members get access to the next funding round first, on a first-come, first-served basis.

ReLift patient before and 24 hours after — Actual ReLift® patient, 24 hours after his procedure.

The procedure

Results in hours, not months.

Performed in about an hour under local anesthesia with oral sedation, by board-certified plastic surgeons in their own practices. No general anesthesia and no visible scars.

Why investors are joining*

Paid along the way, then rewarded at the exit.

Strong early returns · long-term upside

A two-phase investor outcome.

100% of net profits go to investors first, targeting a 25% IRR over 3–5 years and a full return of capital. Equity then participates in two liquidity events.

25%Target IRR over 3–5 years from distributions.

5x+Targeted ROI from Fabrication.

8x+Targeted ROI with an IPO of the MSO.

A unique liquidity provision

Redeemable shares, no liquidity trap.

Private investments usually lock capital up for years. ReLiftMD™ investors may request a repurchase of invested capital through redeemable shares, a 100% return of capital, subject to available liquidity.*

That lets you redeploy capital elsewhere after realizing meaningful gains.

Generate ROI

Distributions paid to investors first.

Recover capital

Redeemable shares at the full initial value.

Maintain optionality

Stay in for the exit, or step out.

Real patients · Real recovery

Ten years younger, in one hour.

Every ReLift® procedure uses ReLiftMD™ proprietary materials, which is what makes each new center part of one national platform.

ReLift patient before and one week after — Actual ReLift® patient, one week after her procedure.

ReLift patient before and two weeks after — Actual ReLift® patient, two weeks after her procedure.

ReLift patient before and one day after — Actual ReLift® patient, one day after his procedure.

Designed for investors

Investor-friendly protections.

Generate ROIRecover capitalMaintain optionality

Investors first

A cash-first structure distributes 100% of net profits to investors.

Participating preferred

Preferential return of capital, plus a share of any upside.

Liquidity

Redeemable shares allow an exit with 100% return of capital, subject to liquidity.

Non-dilutable equity

Investors cannot be diluted by future small rounds.

Pro rata rights

Right of first refusal on future capital raises.

Information rights

Confidential operating and financial updates.

Tag-along rights

Sell alongside major shareholders.

No capital calls

No additional capital is required after investment.

Live every Monday · 8:00 PM ET · Zoom

Ask the founder directly.

Each Monday, Dr. Adam Summers and COO Curt Clinkinbeard walk through the track record, the five-year build and the offering, then take your questions live.

Dr. Adam SummersFounder & CEO

Curt ClinkinbeardCOO